Key F Inancial Inc Tg Therapeutics, Inc. Transaction History
Key F Inancial Inc
- $433 Million
- Q4 2024
A detailed history of Key F Inancial Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Key F Inancial Inc holds 2,000 shares of TGTX stock, worth $84,940. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$84,940
Previous $46,000
30.43%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
373Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$662 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$484 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$391 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$136 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$119 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $6.17B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...